Page last updated: 2024-08-16

4-nitrobenzylthioinosine and Adverse Drug Event

4-nitrobenzylthioinosine has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denich, D; Gärtner, F; Ohmle, B; Parmar, S; Pitterle, K; Seeringer, A; Stingl, JC; Syrovets, T1

Other Studies

1 other study(ies) available for 4-nitrobenzylthioinosine and Adverse Drug Event

ArticleYear
Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
    Pharmacogenomics, 2011, Volume: 12, Issue:4

    Topics: Adult; Antimetabolites, Antineoplastic; Cell Survival; Cells, Cultured; Cytarabine; Cytidine Deaminase; Drug-Related Side Effects and Adverse Reactions; Equilibrative Nucleoside Transporter 1; Exons; Female; Genotype; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Thioinosine; Young Adult

2011